-
Mugwanya KK, Matemo D, Scoville CW, Beima-Sofie KM, Meisner A, Onyango D, Mugambi M, Feutz E, Grabow C, Barnabas R, Weiner B, Baeten JM, Kinuthia J. (2021) "Integrating PrEP delivery in public health family planning clinics: a protocol for a pragmatic stepped wedge cluster randomized trial in Kenya." Implementation Science Communications. 2(1): 1-12.
-
Meisner A, Carone M, Pepe MS, Kerr KF. (2021) "Combining biomarkers by maximizing the true positive rate for a fixed false positive rate." Biometrical Journal. 63(6): 1223-1240.
-
Meisner A, Parikh CR, Kerr KF. (2020) "Developing biomarker combinations in multicenter studies via direct maximization and penalization." Statistics in Medicine. 39(24): 3412-3426.
-
Meisner A, Kundu P, Zhang YD, Lan LV, Kim S, Ghandwani D, Choudhury PP, Berndt SI, Freedman ND, Garcia-Closas M, Chatterjee N. (2020) "Combined utility of 25 disease and risk factor polygenic risk scores for stratifying risk of all-cause mortality." American Journal of Human Genetics. 107(3): 418-431.
-
Meisner A, Kundu P, Chatterjee N. (2019) "Case-only analysis of gene-environment interactions using polygenic risk scores." American Journal of Epidemiology. 188(11): 2013-2020.
-
Meisner A, Chatterjee N. (2019) "Disease Risk Models." In: Handbook of Statistical Genomics, 4th Edition. Balding DJ, Moltke I, Marioni J (Eds). Wiley.
-
Meisner A, Parikh CR, Kerr KF. (2019) "Biomarker combinations for diagnosis and prognosis in multicenter studies: principles and methods." Statistical Methods in Medical Research. 28(4): 969–985. Supplementary material.
-
Meisner A, Parikh CR, Kerr KF. (2018) "Using ordinal outcomes to construct and select biomarker combinations for single-level prediction." Diagnostic and Prognostic Research. 2: 8. R package: multiselect.
-
Meisner A, Kerr KF, Thiessen-Philbrook H, Wilson FP, Garg AX, Shlipak MG, Kavsak P, Whitlock RP, Coca SG, Parikh CR. (2018) "Development of biomarker combinations for postoperative acute kidney injury via Bayesian model selection in a multicenter cohort study." Biomarker Research. 6: 3.
-
Nadkarni GN, Coca SG, Meisner A, Patel S, Kerr KF, Patel UD, Koyner JL, Garg AX, Thiessen-Philbrook H, Edelstein CL, Shlipak M, El-Khoury J, Parikh CR. (2017) "Urinalysis findings and urinary kidney injury biomarker concentrations." BMC Nephrology. 18: 218.
-
Kerr KF, Roth J, Zhu K, Thiessen-Philbrook H, Meisner A, Wilson FP, Coca S, Parikh CR. (2017) "Evaluating biomarkers for prognostic enrichment of clinical trials." Clinical Trials. 14(6): 629–638
-
Graff RE, Meisner A, Ahearn TU, Fiorentino M, Loda M, Giovannucci EL, Mucci LA, Pettersson A. (2016) "Pre-diagnostic circulating sex hormone levels and risk of prostate cancer by ERG tumour protein expression." British Journal of Cancer. 114(8): 939–944.
-
Meisner A, Kerr KF, Thiessen-Philbrook H, Coca SG, Parikh CR. (2016) "Biomarker combinations for predicting acute kidney injury: methodological issues in current practice." Kidney International. 89(2): 429–438.
-
Snyder JM, Meisner A, Mack DL, Goddard MA, Coulter IT, Grange RW, Childers MK. (2015) "Validity of a neurological scoring system for canine X-linked myotubular myopathy." Human Gene Therapy Clinical Development. 26(2): 131–137.
-
Kerr KF, Meisner A, Thiessen-Philbrook H, Coca SG, Parikh CR. (2015) "RiGoR: reporting guidelines to address common sources of bias in risk model development." Biomarker Research. 3(1): 2.
-
Yoo S, Pettersson A, Jordahl KM, Lis RT, Lindstrom S, Meisner A, Nuttall EJ, Stack EC, Stampfer MJ, Kraft P, Brown M, Loda M, Giovannucci EL, Kantoff PW, Mucci LA. (2014) "Androgen receptor CAG repeat polymorphism and risk of TMPRSS2:ERG-positive prostate cancer." Cancer Epidemiology, Biomarkers and Prevention. 23(10):2027–2031.
-
Kerr KF, Meisner A, Thiessen-Philbrook H, Coca SG, Parikh CR. (2014) "Developing risk prediction models for kidney injury and assessing incremental value for novel biomarkers." Clinical Journal of the American Society of Nephrology. 9(8): 1488–1496.
-
Pettersson A, Lis RT, Meisner A, Flavin R, Stack EC, Fiorentino M, Finn S, Graff RE, Penney KL, Rider JR, Nuttall EJ, Martin NE, Sesso HD, Pollak M, Stampfer MJ, Kantoff PW, Giovannucci EL, Loda M, Mucci LA. (2013) "Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG." Journal of the National Cancer Institute. 105(24): 1881–1890.
-
Doros G, Pencina M, Rybin D, Meisner A, Fava M. (2013) "A repeated measures model for analysis of continuous outcomes in sequential parallel comparison design studies." Statistics in Medicine. 32(16): 2767–2789.
-
Schoenfeld JD, Margalit DN, Kasperzyk JL, Shui IM, Rider JR, Epstein MM, Meisner A, Kenfield SA, Martin NE, Nguyen PL, Kantoff PW, Giovannucci EL, Stampfer MJ, Mucci LA. (2013) "A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer." Clinical Cancer Research. 19(6): 1612–1619.
-
Papakostas GI, Shelton RC, Zajecka JM, Etemad B, Rickels K, Clain A, Baer L, Dalton ED, Sacco GR, Schoenfeld D, Pencina M, Meisner A, Bottiglieri T, Nelson E, Mischoulon D, Alpert JE, Barbee JG, Zisook S, Fava M. (2012) "L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials." American Journal of Psychiatry. 169(12):1267–1274.
-
Papakostas GI, Vitolo OV, Ishak WW, Rapaport MH, Zajecka JM, Kinrys G, Mischoulon D, Lipkin SH, Hails KA, Abrams J, Ward SG, Meisner A, Schoenfeld DA, Shelton RC, Winokur A, Okasha MS, Bari MA, Fava M. (2012) "A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder." Journal of Clinical Psychiatry. 73(12):1541–1547.
-
Polak JF, Meisner A, Pencina MJ, Wolf PA, D'Agostino RB. (2012) "Variations in common carotid artery intima-media thickness during the cardiac cycle: implications for cardiovascular risk assessment." Journal of the American Society of Echocardiography. 25(9): 1023-1028.
-
Widera C, Pencina MJ, Meisner A, Kempf T, Bethmann K, Marquardt I, Katus HA, Giannitsis E, Wollert KC. (2012) "Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome." European Heart Journal. 33(9): 1095–1104.
-
Polak JF, Pencina MJ, Meisner A, Pencina KM, Brown LS, Wolf PA, D'Agostino RB Sr. (2010) "Associations of carotid artery intima-media thickness (IMT) with risk factors and prevalent cardiovascular disease: comparison of mean common carotid artery IMT with maximum internal carotid artery IMT." Journal of Ultrasound Medicine. 29(12): 1759–1768.
-
Moore LE, Brennan P, Karami S, Menashe I, Berndt SI, Dong LM, Meisner A, Yeager M, Chanock S, Colt J, Schwartz K, Davis F, Zaridze D, Mattveev V, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Holcatova I, Boffetta P, Chow WH, Rosenberg PS, Rothman N. (2009) "Apolipoprotein E/C1 locus variants modify renal cell carcinoma risk." Cancer Research. 69(20): 8001–8008.